Karl V. Sitz

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

R. Redfield, C. Tacket, D. Birx, 2000, The Journal of infectious diseases.

Recommendations and Reports Anergy Skin Testing and Preventive Therapy for Hiv-infected Persons: Revised Recommendations Managing Editor Visual Information Specialist the following Cdc Staff Members Prepared This Report: Anergy Skin Testing and Preventive Therapy for Hiv-infected Persons: Revised Re

Atlanta, J. Ellner, M. Oxtoby, 2022 .

Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cells.

R. Redfield, D. Birx, S. Ratto, 1994, Human gene therapy.